Tag » Hepatitis B

Milk thistle for chronic hepatitis B

This article was published in the December 2016 edition of Medical Observer, under the title, “Does milk thistle do any good?” (pp. 64-65). ( 967 kata lagi

Michael Tam

Ontario pharmacists will provide travel vaccines in addition to flu shots

TORONTO – Ontario is expanding the number of vaccines available at pharmacies to include protection against an additional 13 preventable diseases.

Common travel vaccines for hepatitis A and B, typhoid, rabies, HPV and shingles will be available at pharmacies for anyone over age of five starting Dec. 100 kata lagi

Health

Larsa Pippen Steps Out at Art Basel Event After Shocking Scottie Pippen Split

Larsa Pippen hit Art Basel week in Miami on Wednesday — stepping out at a public event for the first time since her husband, NBA legend Scottie Pippen, filed for… 425 kata lagi

Celebrity

CONSULTATIVE MEETING ON MALABA HEALTH CENTRE 4 REVEALS HEPATITIS B VACCINES ARE BEING SOLD TO PATIENTS.

In a consultative meeting called for by Hon. Imailuk Rogers Peter today at Malaba town council to brainstorm on the possibility of having Malaba health centre 3 upgraded to Malaba health 4, it was realized that the proposed land for upgrading the health centre 3 is available. 346 kata lagi

News

Requirements for global elimination of hepatitis B: a modelling study

Lancet Infectious Diseases December 2016 V.16 N.12 P.1399–1408

Dr Shevanthi Nayagam, MBBS, Prof Mark Thursz, MD, Elisa Sicuri, PhD, Lesong Conteh, PhD, Stefan Wiktor, MD, Daniel Low-Beer, PhD, Prof Timothy B Hallett, PhD… 366 kata lagi

Metodos Diagnosticos

Comment - Eliminating hepatitis B virus as a global health threat

Lancet Infectious Diseases December 2016 V.16 N.12 P.1313–1314

Grace Lai-Hung Wong, Vincent Wai-Sun Wong

In The Lancet Infectious Diseases, Shevanthi Nayagam and colleagues1 report a modelling study on the effectiveness of different interventions on the incidence and mortality rate of chronic hepatitis B virus (HBV) infection. 137 kata lagi

Metodos Diagnosticos

Dynavax trips on FDA's rejection for hepatitis B vaccine, drops over 62% on intraday trading

Dynavax Technologies Corporation has received a rejection from the FDA for its Heplisav-B, hepatitis B vaccine. In a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for Heplisav B for immunization of adults 18 years and older against hepatitis B infection. 347 kata lagi

News